A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
R. Benecke(Children's Hospital of Philadelphia), Susanne Grafe(Deutsche Klinik für Diagnostik), Georg Comes(Deutsche Klinik für Diagnostik), W. H. Jost(Deutsche Klinik für Diagnostik), Petr Kaňovský(University Hospital Olomouc), Evžen Růžička(Charles University)
Cited by 273
Related Papers
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
|European Journal of Neurology|2012|490
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
|The Lancet Neurology|2018|345
Transcranial magnetic stimulation of the human brain: responses in muscles supplied by cranial nerves
|Experimental Brain Research|1988|304
On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects
|Experimental Brain Research|1993|303